Bioactive Compounds in Health and Disease
SJR0.314
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.314 | Q3 | 45.1% | |
| 2024 | — | — | 0.309 | Q3 | 46.6% | |
| 2023 | — | — | 0.355 | Q3 | 53.9% | |
| 2022 | — | — | 0.268 | Q3 | 47.1% | |
| 2021 | — | — | — | 9.9% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2769-2426
ISSN
2574-0334
region
Northern America
coverage
2018-2026